Search the Newsreel

Alignment Healthcare, Inc. (ALHC) Stock Analysis: A Strong Buy With 18% Potential Upside

Alignment Healthcare, Inc. (ALHC) is presented as a compelling investment opportunity in the healthcare sector, particularly appealing to growth-oriented investors. With a market capitalization of $4.36 billion, the company focuses on Medicare Advantage plans for seniors, showing strong revenue growth of 33.30% and an …

Kaplan Fox Notifies Investors of Alignment Healthcare, Inc. (NASDAQ: ALHC) of an Investigation Into Potential Securities Law Violations

Kaplan Fox & Kilsheimer LLP is investigating Alignment Healthcare, Inc. (NASDAQ: ALHC) for potential securities law violations after a whistleblower complaint alleged "accounting irregularities" that artificially inflated the company's financial results and executive compensation. Following news of the complaint on July 8, 2026, Alignment …

ALIGNMENT HEALTHCARE INVESTOR ALERT: Bragar Eagel & Squire,

Bragar Eagel & Squire, P.C. is investigating potential claims against Alignment Healthcare, Inc. (NASDAQ:ALHC) following allegations of financial manipulation. A former executive filed a whistleblower lawsuit claiming the company misclassified operating expenses as capital expenditures to inflate its adjusted EBITDA and stock price. Following …

Alight to Announce Second Quarter 2026 Results

CHICAGO, July 21, 2026--(BUSINESS WIRE)--Alight, Inc. (NYSE: ALIT or "Alight") today announced it will release second quarter 2026 earnings results after market close on Tuesday, August 4, 2026, and management will host a webcast to discuss the results at 4:30 p.m. ET. The webcast …

Align Technology (ALGN) Q4 2024 Earnings Report - Results, Call & Slides

Align Technology (ALGN) released its Q4 2024 earnings report, revealing an EPS of $2.44, which slightly missed the consensus estimate of $2.45. The company also reported actual revenue of $995.22 million, missing the expected $996.90 million. YoY revenue growth was 4.02%, and the earnings …

Alight management will discuss Q2 results Aug. 4 at 4:30 p.m.

Align Technology stock is supported by recent earnings metrics

Align Technology's stock is supported by its 2025 financial metrics, which include $4.0 billion in revenue, $470.6 million in net income, and diluted EPS of $6.43. These figures provide a concrete basis for evaluating the company's valuation and operational health. The article emphasizes using …

ALHC SHAREHOLDER ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations

Kirby McInerney LLP is investigating Alignment Healthcare, Inc. (NASDAQ: ALHC) regarding potential securities laws violations. This follows a whistleblower lawsuit alleging that Alignment Healthcare manipulated its finances by misclassifying operating expenses as capital expenditures, artificially inflating its stock price and executive compensation. The firm …

Block & Leviton probes Alignment Healthcare for alleged securities violations after whistleblower lawsuit.

Block & Leviton is investigating Alignment Healthcare (ALHC) for alleged securities violations, stemming from a whistleblower lawsuit. The lawsuit claims the company manipulated financial results to inflate its stock price and executive compensation. This follows a significant 16.72% stock drop after the lawsuit news, …

Bronstein, Gewirtz & Grossman, LLC Is Investigating Alignment Hea

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against Alignment Healthcare, Inc. (NASDAQ:ALHC) following a whistleblower lawsuit. The lawsuit alleges that Alignment manipulated its finances by misclassifying operating expenses as capital expenditures to artificially inflate its adjusted EBITDA, leading to a significant drop …

Leerink Partners Adjusts Price Target on Align Technology to $235 From $230, Maintains Outperform Rating

Leerink Partners has increased its price target for Align Technology (ALGN) from $230 to $235, while reiterating its Outperform rating. This adjustment reflects a positive outlook on the company's stock performance.

Align Technology to Report Q2 Earnings: Clear Aligner Segment in Focus

Align Technology, Inc. ALGN is set to release second-quarter 2026 results on July 29, after the closing bell. In the last reported quarter, the company posted adjusted earnings per share (EPS) of $2.58, which surpassed the Zacks Consensus Estimate by 14.16%. Align Technology beat …

Align Technology stock trades near yearly lows as investors weigh margin pressure and Invisalign gro

Align Technology stock is trading near its 52-week low as investors assess softer demand for clear aligners, margin pressure, and the company's latest earnings report guidance. Despite reporting nearly $4 billion in revenue for 2023, the dental device maker saw its operating margin contract …

Align Technology stock trades near 52-week high as Invisalign demand supports growth

Align Technology's stock is trading near its 52-week high, driven by strong demand for its Invisalign clear aligner system and the expanding adoption of iTero scanners in dental practices. The company has demonstrated sustained revenue growth, profitability, and global expansion by offering diversified income …

How Investors May Respond To Align Technology (ALGN) Losing Its Chief Legal and Regulatory Officer

Align Technology's Chief Legal and Regulatory Officer, Julie Coletti, is resigning to join Illumina, Inc. This leadership change could influence how investors perceive Align's governance and risk oversight, especially amidst its broader governance refresh and investments in new products. While the departure doesn't immediately …

Diluted net income available to common stockholders of Alight, Inc. Class A – DUS:A9L1

This page provides financial data for Alight, Inc. Class A (DUS:A9L1) on the Dusseldorf Stock Exchange. Specifically, it highlights the "Diluted net income available to common stockholders" for the company. The page appears to be a financial overview with no active trading data at …

Kaplan Fox is Investigating Alignment Healthcare, Inc. (NASDAQ: ALHC) for Potential Securities Law Violations

Kaplan Fox & Kilsheimer LLP is investigating Alignment Healthcare, Inc. (NASDAQ: ALHC) for potential securities law violations following a whistleblower complaint. The complaint alleges accounting irregularities that falsely inflated the company's financial results, specifically through misclassifying operating expenses as capital expenditures. This news led …

Kaplan Fox Announces a Securities Investigation into Alignment Healthcare, Inc. (ALHC) - Investors Encouraged to Contact the Firm

Kaplan Fox & Kilsheimer LLP has launched a securities investigation into Alignment Healthcare, Inc. (ALHC) following allegations by a former executive of "accounting irregularities" that "artificially inflated" the company's financial results. The complaint suggests that operating expenses were misclassified as capital expenditures, leading to …

ETFs Investing in Align Technology, Inc. Stocks

This article lists various Exchange Traded Funds (ETFs) that hold stocks of Align Technology, Inc. (ALGN). It provides a detailed table including each ETF's market value, weight of ALGN stock, issuer, management style, focus, expense ratio, assets under management (AUM), current price, price change, …

Align Technology stock trades near recent highs as Invisalign demand supports growth

Align Technology's stock is performing well, driven by strong demand for its Invisalign clear aligners and double-digit revenue growth. The company reported resilient margins and increased case shipments, especially in its clear aligner business and iTero scanner segment. Align Technology continues to invest in …

(ALGN) and the Role of Price-Sensitive Allocations

Align Technology Inc. (NASDAQ: ALGN) is showing a near-term neutral sentiment while maintaining mid and long-term strength, with a mid-channel oscillation pattern observed. AI models have generated three distinct trading strategies for different risk profiles: a long position trading strategy, a breakout strategy, and …

Alignment Healthcare (NASDAQ: ALHC) president trades 177K shares, exercises options

Alignment Healthcare's president, Dawn Christine Maroney, exercised options for 152,068 shares at $9.06 per share and subsequently sold 177,068 shares at a weighted-average price of $20.8281 per share under a Rule 10b5-1 trading plan. The transactions, which occurred on July 15, 2026, resulted in …

What to expect from Align Technology’s next quarterly earnings report

This article is a placeholder, as the provided content only contains "MSN". Therefore, a meaningful summary cannot be generated.

Reasons to Retain Alignment Healthcare Stock in Your Portfolio for Now

Alignment Healthcare (ALHC) is poised for growth due to its strong balance sheet and significant investments in automation and AI, which are enhancing operational efficiency and expanding margins. However, the company faces near-term challenges from the transition to the CMS V28 risk adjustment model …

Kaplan Fox Reminds Investors of an Ongoing Investigation Into Alignment Healthcare, Inc. (NASDAQ: ALHC) for Possible Securities Law Violations

Kaplan Fox & Kilsheimer LLP is investigating Alignment Healthcare, Inc. (NASDAQ: ALHC) for potential securities law violations following a whistleblower complaint. The complaint alleges "accounting irregularities" that "artificially inflated" the company's financial results by misclassifying operating expenses as capital expenditures. Following this news on …

ALHC (NASDAQ: ALHC) insider plans sale of 177,068 common shares

A Form 144 filing indicates a proposed sale of 177,068 shares of Alignment Healthcare (ALHC) common stock with an aggregate market value of over $3.7 million. These shares originate from stock options exercised and RSU/PSU awards, and the sale will be facilitated by Morgan …

Align Technology Named Title Sponsor of Operation Smile Student Conference

Align Technology will be the title sponsor of Operation Smile's 2026 International Student Leadership Conference (ISLC) in Bangkok, Thailand, marking their sixth consecutive year of support. The company has contributed nearly $3.8 million to Operation Smile's programs and will fund 100 student scholarships for …

H.C. Wainwright Maintains Aligos Therapeutics(ALGS.US) With Buy Rating, Maintains Target Price $50

H.C. Wainwright has reiterated its Buy rating for Aligos Therapeutics (ALGS.US) and maintained a target price of $50. This indicates a continued positive outlook from the analyst firm regarding the company's stock performance and potential.

Alignment healthcare CEO John Kao sells $5.9m in ALHC shares

John E. Kao, CEO of Alignment Healthcare (NASDAQ:ALHC), sold 298,000 shares worth approximately $5.92 million on July 10, 2026, through a pre-arranged trading plan. This sale occurred while the stock declined 15% over the past week but remains up 52% over the last year. …

A Look at Alignment Healthcare Inc (ALHC) After 4.0% Gain -- GF Value $19.34 vs Price $21.21

Alignment Healthcare Inc (ALHC) shares gained 4.0% to $21.21, but are considered 9.7% overvalued according to GuruFocus' GF Value of $19.34. The stock has a GF Score of 78/100, indicating good long-term potential, though profitability and momentum scores are low. Insider selling totaling $15.8 …

BDR Align Technology - A1LG34 - Resultados, Dividendos, Cotação e Indicadores

Dialight plc (DIA.L) stock historical prices and data